CM – UPDATE: Baird is upgrading Biogen (BIIB) to neutral

Keywords:

NASDAQ:BIIB,Biogen,Stock,Nasdaq,NASDAQ:BIIB, Biogen, Stock, Nasdaq,,,,,aducanumab,aducanumab fda approval,aducanumab stock,aduhelm,biib,biib news,biib stock,biogen,biogen aducanumab,biogen alzheimer’s drug,biogen fda,biogen news,biogen stock,biogen stock price,blue stock,dow futures,evfm stock,fda aducanumab,fda biogen,lmnl stock,new alzheimer’s drug,qts stock,rmed stock,stock futures,uscr stock,,,,